RGC

Regencell Bioscience Holdings Limited Ordinary Shares (RGC)

Stock · NASDAQ · Health Care

$9.62as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

RGC among health care stocks moving in Thursday's session. RGC is listed among the health care stocks that were active on Thursday. The stock showed a volume spike and high beta, matching the market's broader move. Its RSI is 77, indicating it is near overbought territory. The support level is $5.48, which has been touched 39 times.

Active signals

Support level
$5.48
Industry
Medicinal Chemicals and Botanical Products

What RGC's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike49-12.0%29%
Bollinger Band Breakdown23-8.6%30%
Bollinger Band BreakoutActive now20-6.7%30%
200-Day Moving Average TouchActive now10-6.9%30%
Any 20-session window (baseline)-6.4%38%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About RGC

Regencell Bioscience Holdings Limited focuses on the research, development, and commercialization of Traditional Chinese Medicine (TCM) in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, TCM brain theory, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2…

Sector
Health Care
Industry
Medicinal Chemicals and Botanical Products
Employees
10

Fundamentals

1-day range
$8.83$10.33
Market cap
$2.70B
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
$-0.02
Dividend yield
—
Beta
1.84
Avg. volume
222.5K
52-week range
$4.51$69
Next earnings: October 28, 2026

Regencell Bioscience Holdings Limited Ordinary Shares Competitors

Chosen by industry and closest market cap.

  • RGC
    Regencell Bioscience Holdings Limited Ordinary Shares
    $9.59
    ▲ 0.74%
    Market cap $2.70BP/E —
    $4.51$69
  • RLX
    RLX Technology Inc. American Depositary Shares each representing the right to receive one (1) Class A ordinary share
    $1.7
    ▼ 0.58%
    Market cap $3.08BP/E 14.19
    $1.65$2.6
  • TRLV
    Trulieve Cannabis Corp. Subordinate Voting Shares
    $10.01
    ▼ 2.82%
    Market cap $1.73BP/E —
    $7.82$12.93
  • CRON
    Cronos Group Inc. Common Share
    $3.21
    ▲ 0.31%
    Market cap $1.16BP/E 16.88
    $3.23$4.99
  • GLAS
    Glass House Brands Inc. Subordinate Voting Shares
    $3.19
    ▼ 14.02%
    Market cap $760.64MP/E —
    $4.2$14
  • TLRY
    Tilray Brands Inc. Common Stock
    $3.04
    ▼ 5.30%
    Market cap $517.36MP/E —
    $3.07$18.4
  • CGC
    Canopy Growth Corporation Common Shares
    $0.713
    ▼ 3.13%
    Market cap $400.49MP/E —
    $1.05$3.28

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
0
Disposed
89.6K
  • HUI EVANA YEE WAH · May 27, 2026 · Disposition
    19.0K
  • LO WILLIAM WING YAN DR · May 27, 2026 · Disposition
    70.6K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.